Serum <i>N</i>-Glycomics Stratifies Bacteremic Patients Infected with Different Pathogens

Bacteremia—i.e., the presence of pathogens in the blood stream—is associated with long-term morbidity and is a potential precursor condition to life-threatening sepsis. Timely detection of bacteremia is therefore critical to reduce patient mortality, but existing methods lack precision, speed, and s...

Full description

Bibliographic Details
Main Authors: Sayantani Chatterjee, Rebeca Kawahara, Harry C. Tjondro, David R. Shaw, Marni A. Nenke, David J. Torpy, Morten Thaysen-Andersen
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/3/516
_version_ 1797416992385269760
author Sayantani Chatterjee
Rebeca Kawahara
Harry C. Tjondro
David R. Shaw
Marni A. Nenke
David J. Torpy
Morten Thaysen-Andersen
author_facet Sayantani Chatterjee
Rebeca Kawahara
Harry C. Tjondro
David R. Shaw
Marni A. Nenke
David J. Torpy
Morten Thaysen-Andersen
author_sort Sayantani Chatterjee
collection DOAJ
description Bacteremia—i.e., the presence of pathogens in the blood stream—is associated with long-term morbidity and is a potential precursor condition to life-threatening sepsis. Timely detection of bacteremia is therefore critical to reduce patient mortality, but existing methods lack precision, speed, and sensitivity to effectively stratify bacteremic patients. Herein, we tested the potential of quantitative serum <i>N</i>-glycomics performed using porous graphitized carbon liquid chromatography tandem mass spectrometry to stratify bacteremic patients infected with <i>Escherichia coli</i> (<i>n</i> = 11), <i>Staphylococcus aureus</i> (<i>n</i> = 11), <i>Pseudomonas aeruginosa</i> (<i>n</i> = 5), and <i>Streptococcus viridans</i> (<i>n</i> = 5) from healthy donors (<i>n</i> = 39). In total, 62 <i>N</i>-glycan isomers spanning 41 glycan compositions primarily comprising complex-type core fucosylated, bisecting <i>N</i>-acetylglucosamine (GlcNAc), and α2,3-/α2,6-sialylated structures were profiled across all samples using label-free quantitation. Excitingly, unsupervised hierarchical clustering and principal component analysis of the serum <i>N</i>-glycome data accurately separated the patient groups. <i>P. aeruginosa</i>-infected patients displayed prominent <i>N</i>-glycome aberrations involving elevated levels of fucosylation and bisecting GlcNAcylation and reduced sialylation relative to other bacteremic patients. Notably, receiver operating characteristic analyses demonstrated that a single <i>N</i>-glycan isomer could effectively stratify each of the four bacteremic patient groups from the healthy donors (area under the curve 0.93–1.00). Thus, the serum <i>N</i>-glycome represents a new hitherto unexplored class of potential diagnostic markers for bloodstream infections.
first_indexed 2024-03-09T06:12:25Z
format Article
id doaj.art-3037aec27d934c3792597d5a65dcd1f5
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T06:12:25Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-3037aec27d934c3792597d5a65dcd1f52023-12-03T11:56:48ZengMDPI AGJournal of Clinical Medicine2077-03832021-02-0110351610.3390/jcm10030516Serum <i>N</i>-Glycomics Stratifies Bacteremic Patients Infected with Different PathogensSayantani Chatterjee0Rebeca Kawahara1Harry C. Tjondro2David R. Shaw3Marni A. Nenke4David J. Torpy5Morten Thaysen-Andersen6Department of Molecular Sciences, Macquarie University, Sydney, NSW 2109, AustraliaDepartment of Molecular Sciences, Macquarie University, Sydney, NSW 2109, AustraliaDepartment of Molecular Sciences, Macquarie University, Sydney, NSW 2109, AustraliaInfectious Diseases Clinic, Royal Adelaide Hospital, Adelaide, SA 5000, AustraliaEndocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, SA 5000, AustraliaEndocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, SA 5000, AustraliaDepartment of Molecular Sciences, Macquarie University, Sydney, NSW 2109, AustraliaBacteremia—i.e., the presence of pathogens in the blood stream—is associated with long-term morbidity and is a potential precursor condition to life-threatening sepsis. Timely detection of bacteremia is therefore critical to reduce patient mortality, but existing methods lack precision, speed, and sensitivity to effectively stratify bacteremic patients. Herein, we tested the potential of quantitative serum <i>N</i>-glycomics performed using porous graphitized carbon liquid chromatography tandem mass spectrometry to stratify bacteremic patients infected with <i>Escherichia coli</i> (<i>n</i> = 11), <i>Staphylococcus aureus</i> (<i>n</i> = 11), <i>Pseudomonas aeruginosa</i> (<i>n</i> = 5), and <i>Streptococcus viridans</i> (<i>n</i> = 5) from healthy donors (<i>n</i> = 39). In total, 62 <i>N</i>-glycan isomers spanning 41 glycan compositions primarily comprising complex-type core fucosylated, bisecting <i>N</i>-acetylglucosamine (GlcNAc), and α2,3-/α2,6-sialylated structures were profiled across all samples using label-free quantitation. Excitingly, unsupervised hierarchical clustering and principal component analysis of the serum <i>N</i>-glycome data accurately separated the patient groups. <i>P. aeruginosa</i>-infected patients displayed prominent <i>N</i>-glycome aberrations involving elevated levels of fucosylation and bisecting GlcNAcylation and reduced sialylation relative to other bacteremic patients. Notably, receiver operating characteristic analyses demonstrated that a single <i>N</i>-glycan isomer could effectively stratify each of the four bacteremic patient groups from the healthy donors (area under the curve 0.93–1.00). Thus, the serum <i>N</i>-glycome represents a new hitherto unexplored class of potential diagnostic markers for bloodstream infections.https://www.mdpi.com/2077-0383/10/3/516bacteremiabiomarkermass spectrometry<i>N</i>-glycan<i>N</i>-glycomicsporous graphitized carbon
spellingShingle Sayantani Chatterjee
Rebeca Kawahara
Harry C. Tjondro
David R. Shaw
Marni A. Nenke
David J. Torpy
Morten Thaysen-Andersen
Serum <i>N</i>-Glycomics Stratifies Bacteremic Patients Infected with Different Pathogens
Journal of Clinical Medicine
bacteremia
biomarker
mass spectrometry
<i>N</i>-glycan
<i>N</i>-glycomics
porous graphitized carbon
title Serum <i>N</i>-Glycomics Stratifies Bacteremic Patients Infected with Different Pathogens
title_full Serum <i>N</i>-Glycomics Stratifies Bacteremic Patients Infected with Different Pathogens
title_fullStr Serum <i>N</i>-Glycomics Stratifies Bacteremic Patients Infected with Different Pathogens
title_full_unstemmed Serum <i>N</i>-Glycomics Stratifies Bacteremic Patients Infected with Different Pathogens
title_short Serum <i>N</i>-Glycomics Stratifies Bacteremic Patients Infected with Different Pathogens
title_sort serum i n i glycomics stratifies bacteremic patients infected with different pathogens
topic bacteremia
biomarker
mass spectrometry
<i>N</i>-glycan
<i>N</i>-glycomics
porous graphitized carbon
url https://www.mdpi.com/2077-0383/10/3/516
work_keys_str_mv AT sayantanichatterjee seruminiglycomicsstratifiesbacteremicpatientsinfectedwithdifferentpathogens
AT rebecakawahara seruminiglycomicsstratifiesbacteremicpatientsinfectedwithdifferentpathogens
AT harryctjondro seruminiglycomicsstratifiesbacteremicpatientsinfectedwithdifferentpathogens
AT davidrshaw seruminiglycomicsstratifiesbacteremicpatientsinfectedwithdifferentpathogens
AT marnianenke seruminiglycomicsstratifiesbacteremicpatientsinfectedwithdifferentpathogens
AT davidjtorpy seruminiglycomicsstratifiesbacteremicpatientsinfectedwithdifferentpathogens
AT mortenthaysenandersen seruminiglycomicsstratifiesbacteremicpatientsinfectedwithdifferentpathogens